Skip to main content
Erschienen in: Clinical and Experimental Nephrology 4/2008

01.08.2008 | Case Report

Oxalate nephropathy with a granulomatous lesion due to excessive intake of peanuts

verfasst von: Masamitsu Sasaki, Masaaki Murakami, Ken Matsuo, Yoko Matsuo, Satoshi Tanaka, Takahiko Ono, Noriko Mori

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

A 65-year-old Japanese male developed renal dysfunction, showing proteinuria and marked urinary excretion of β2-microglobulin. He had consumed approximately 100–200 g peanuts and 750–1,000 ml beer every day for two or three months. He had previously been treated for hypertension with an angiotensin-converting enzyme inhibitor, enalapril. He then visited his primary-care doctor with mild fever, and renal dysfunction with mild diabetes mellitus were diagnosed. He was referred to our hospital, and because no diabetic retinopathy was observed by ophthalmological tests, renal biopsy examination was performed to clarify renal dysfunction. Renal biopsy specimens showed intimal thickening in the small arteries and interstitial nephritis with a granulomatous lesion, accompanied by oxalate crystals under polarized light. Glomeruli were unremarkable without any immunoglobulin deposition, and nodular lesions. Because he daily consumed a large amount of peanuts, oxalate nephropathy due to excessive intake of peanuts was strongly suspected. This case revealed that unusual food habits, including nuts, can cause oxalate nephropathy, and that close examination by renal biopsy was useful for clarifying the etiology of the unknown renal damage.
Literatur
1.
Zurück zum Zitat Lorenzo V, Alvarez A, Torres A, Torregrosa V, Hernández D, Salido E. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: single-center experience. Kidney Int. 2006;70:1115–9.CrossRef Lorenzo V, Alvarez A, Torres A, Torregrosa V, Hernández D, Salido E. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: single-center experience. Kidney Int. 2006;70:1115–9.CrossRef
2.
Zurück zum Zitat Hoppe B, Leumann E. Diagnostic and therapeutic strategies in hyperoxaluria: a plea for early intervention. Nephrol Dial Transplant. 2004;19:39–42.CrossRef Hoppe B, Leumann E. Diagnostic and therapeutic strategies in hyperoxaluria: a plea for early intervention. Nephrol Dial Transplant. 2004;19:39–42.CrossRef
3.
Zurück zum Zitat Hill GS. Calcium and the kidney, hydronephrosis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney. Philadelphia: Lippincott–Raven; 1998. pp. 891–936. Hill GS. Calcium and the kidney, hydronephrosis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney. Philadelphia: Lippincott–Raven; 1998. pp. 891–936.
4.
Zurück zum Zitat Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565–9.CrossRef Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565–9.CrossRef
5.
Zurück zum Zitat Mandell I, Krauss E, Millan JC. Oxalate-induced acute renal failure in Crohn’s disease. Am J Med. 1980;69:628–32.CrossRef Mandell I, Krauss E, Millan JC. Oxalate-induced acute renal failure in Crohn’s disease. Am J Med. 1980;69:628–32.CrossRef
6.
Zurück zum Zitat Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int. 1999;56:1899–904.CrossRef Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int. 1999;56:1899–904.CrossRef
7.
Zurück zum Zitat Isonokami M, Nishida K, Okada N, Yoshikawa K. Cutaneous oxalate granulomas in a haemodialysed patient: report of a case with unique clinical features. Br J Dermatol. 1993;128:690–2.CrossRef Isonokami M, Nishida K, Okada N, Yoshikawa K. Cutaneous oxalate granulomas in a haemodialysed patient: report of a case with unique clinical features. Br J Dermatol. 1993;128:690–2.CrossRef
8.
Zurück zum Zitat Böör A, Jurkovic I, Friedmann I, Benický M, Kocan P. Calcium oxalate granuloma of the nose of a chronically dialysed nephritic patient. J Laryngol Otol. 2001;115:514–6.PubMed Böör A, Jurkovic I, Friedmann I, Benický M, Kocan P. Calcium oxalate granuloma of the nose of a chronically dialysed nephritic patient. J Laryngol Otol. 2001;115:514–6.PubMed
9.
Zurück zum Zitat Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol. 2004;8:75–88.CrossRef Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol. 2004;8:75–88.CrossRef
10.
Zurück zum Zitat Yasui T, Fujita K, Asai K, Kohri K. Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells. Int J Urol. 2002;9:100–8.CrossRef Yasui T, Fujita K, Asai K, Kohri K. Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells. Int J Urol. 2002;9:100–8.CrossRef
11.
Zurück zum Zitat Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18:2198–204.CrossRef Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18:2198–204.CrossRef
12.
Zurück zum Zitat Stoller ML, Carroll PR. Urology. In: Tierney LM, McPhee SJ, Papadakis MA, editors. Current medical diagnosis and treatment. New York: McGraw–Hill; 2003. p. 903–45. Stoller ML, Carroll PR. Urology. In: Tierney LM, McPhee SJ, Papadakis MA, editors. Current medical diagnosis and treatment. New York: McGraw–Hill; 2003. p. 903–45.
13.
Zurück zum Zitat Churg J, Cotran RS, Sinniah R, Sakaguchi H, Sobin LH, editors. Tubular and tubulo-interstitial nephropathy caused by metabolic disturbances. In: Renal disease: classification and atlas of tubulo-interstitial diseases. 1st ed. New York, Igaku-Shoin, 1985. p. 157–60. Churg J, Cotran RS, Sinniah R, Sakaguchi H, Sobin LH, editors. Tubular and tubulo-interstitial nephropathy caused by metabolic disturbances. In: Renal disease: classification and atlas of tubulo-interstitial diseases. 1st ed. New York, Igaku-Shoin, 1985. p. 157–60.
14.
Zurück zum Zitat Brinkley LJ, Gregory J, Pak CY. A further study of oxalate bioavailability in foods. J Urol. 1990;144:94–6.CrossRef Brinkley LJ, Gregory J, Pak CY. A further study of oxalate bioavailability in foods. J Urol. 1990;144:94–6.CrossRef
15.
Zurück zum Zitat Ferraz RR, Tiselius HG, Heilberg IP. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion. Kidney Int. 2004;66:676–82.CrossRef Ferraz RR, Tiselius HG, Heilberg IP. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion. Kidney Int. 2004;66:676–82.CrossRef
16.
Zurück zum Zitat Borghi L, Meschi T, Schianchi T, Briganti A, Guerra A, Allegri F, Novarini A. Urine volume: stone risk factor and preventive measure. Nephron. 1999;81 Suppl 1:31–7.CrossRef Borghi L, Meschi T, Schianchi T, Briganti A, Guerra A, Allegri F, Novarini A. Urine volume: stone risk factor and preventive measure. Nephron. 1999;81 Suppl 1:31–7.CrossRef
17.
Zurück zum Zitat Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005;173:1601–5.CrossRef Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005;173:1601–5.CrossRef
Metadaten
Titel
Oxalate nephropathy with a granulomatous lesion due to excessive intake of peanuts
verfasst von
Masamitsu Sasaki
Masaaki Murakami
Ken Matsuo
Yoko Matsuo
Satoshi Tanaka
Takahiko Ono
Noriko Mori
Publikationsdatum
01.08.2008
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 4/2008
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-008-0046-5

Weitere Artikel der Ausgabe 4/2008

Clinical and Experimental Nephrology 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.